tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Can Fite Biopharma Ltd

CANF
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
2.200USD
-0.030-1.34%
์‹œ์žฅ ์šด์˜ ์‹œ๊ฐ„ย 09/23, 09:37๏ผˆET๏ผ‰
4.71M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

CANF ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Can Fite Biopharma Ltd์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
4.71M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
0.00
์ฃผ๋‹น์ˆœ์ด์ต
-1.79K
์ˆ˜์ต
405.00K
์ˆœ์ด์ต
-7.88M
ROE
-178.24%
ROA
-105.48%

Can Fite Biopharma Ltd ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
Mar 26, 2026
EPS / ์˜ˆ์ƒ
--/--
์ˆ˜์ต / ์˜ˆ์ƒ
--/--

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2025Q4
FY2025Q2
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2019Q4
FY2019Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
----
----
----
----
----
----
----
70.00%-0.33
53.55%-0.43
49.44%-0.41
---0.65
---1.11
---0.93
---0.81
----
----
----
----
----
----
----
----
----
----
์ˆ˜์ต
----
----
----
----
----
----
----
-21.32%155.00K
-3.92%196.00K
-3.92%196.00K
-4.39%196.00K
-3.43%197.00K
-18.73%204.00K
-18.40%204.00K
38.51%205.00K
36.00%204.00K
18.96%251.00K
--250.00K
--148.00K
-21.88%150.00K
-81.68%211.00K
----
--192.00K
--1.15M
์ˆœ์ด์ต
----
----
----
----
----
----
----
45.28%-1.65M
30.33%-1.76M
23.78%-1.67M
-4.77%-2.55M
54.99%-3.02M
25.62%-2.53M
31.94%-2.19M
-29.61%-2.43M
-84.64%-6.71M
-32.04%-3.40M
---3.22M
---1.88M
24.06%-3.63M
12.65%-2.58M
----
---4.78M
---2.95M
์ˆœ์ด์ต๋ฅ 
----
----
----
----
----
----
----
30.45%-1065.81%
27.48%-898.98%
20.67%-852.04%
---1301.02%
---1532.49%
---1239.71%
---1074.02%
----
----
----
----
----
----
----
----
----
----
์ด ์ด์ต๋ฅ 
----
----
----
----
----
----
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
----
----
----
----
----
----
----
----
----
----
----
--0.00%
----
----
----
----
----
----
----
----
----
----
----
----
์ˆ˜์ต
----
----
----
----
----
----
----
-21.32%155.00K
-3.92%196.00K
-3.92%196.00K
-4.39%196.00K
-3.43%197.00K
-18.73%204.00K
-18.40%204.00K
38.51%205.00K
36.00%204.00K
18.96%251.00K
--250.00K
--148.00K
-21.88%150.00K
-81.68%211.00K
----
--192.00K
--1.15M
์˜์—… ์ด์ต
----
----
----
----
----
----
----
40.51%-1.83M
27.52%-1.86M
13.82%-1.78M
-14.43%-2.71M
23.46%-3.08M
26.70%-2.57M
33.93%-2.07M
-9.17%-2.37M
-13.37%-4.03M
-41.59%-3.51M
---3.13M
---2.17M
22.95%-3.55M
11.18%-2.48M
----
---4.61M
---2.79M
์ˆœ์ด์ต
----
----
----
----
----
----
----
45.28%-1.65M
30.33%-1.76M
23.78%-1.67M
-4.77%-2.55M
54.99%-3.02M
25.62%-2.53M
31.94%-2.19M
-29.61%-2.43M
-84.64%-6.71M
-32.04%-3.40M
---3.22M
---1.88M
24.06%-3.63M
12.65%-2.58M
----
---4.78M
---2.95M
์œ ๋™์ž์‚ฐ
4.97%8.00M
5.10%9.44M
30.82%7.62M
-9.35%8.98M
----
-46.58%5.83M
----
8.20%9.91M
-27.86%9.06M
-25.22%10.91M
-24.30%13.38M
-54.37%9.16M
-13.19%12.56M
52.72%14.59M
39.98%17.67M
113.49%20.07M
9.32%14.47M
-24.80%9.55M
--12.63M
31.58%9.40M
--13.24M
--12.70M
----
----
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
4.95%2.23M
33.09%2.73M
6.69%2.12M
1.58%2.05M
----
-11.02%1.99M
----
-19.26%2.02M
-20.96%2.21M
3.72%2.23M
-0.45%2.89M
-8.35%2.50M
29.87%2.80M
-8.73%2.15M
41.04%2.90M
115.13%2.73M
18.36%2.15M
57.16%2.36M
--2.06M
-61.20%1.27M
--1.82M
--1.50M
----
----
์ด ์ž์‚ฐ
4.34%8.05M
4.32%9.51M
30.36%7.72M
-8.70%9.12M
----
-46.32%5.92M
----
7.61%9.99M
-27.84%9.17M
-25.19%11.03M
-24.42%13.49M
-54.16%9.28M
-13.20%12.71M
52.33%14.75M
40.06%17.85M
112.67%20.25M
9.85%14.64M
-24.38%9.68M
--12.74M
16.50%9.52M
--13.33M
--12.80M
----
----
๋ถ€์ฑ„ ์ด๊ณ„
-9.50%3.20M
6.46%3.92M
2.70%3.54M
-1.66%3.68M
----
-17.20%3.44M
----
-22.14%3.75M
-25.46%3.93M
-14.34%4.16M
-14.20%5.00M
-18.05%4.81M
-0.51%5.28M
-15.21%4.85M
2.81%5.82M
70.22%5.87M
40.16%5.30M
57.11%5.72M
--5.66M
-39.83%3.45M
--3.79M
--3.64M
----
----
์ž๋ณธ ์ด๊ณ„
16.04%4.86M
2.87%5.59M
68.78%4.18M
-12.93%5.44M
----
-63.94%2.48M
----
39.60%6.24M
-29.52%5.24M
-30.51%6.87M
-29.37%8.49M
-68.91%4.47M
-20.42%7.43M
150.11%9.89M
69.88%12.02M
136.78%14.38M
-2.17%9.33M
-56.80%3.96M
--7.08M
148.73%6.07M
--9.54M
--9.16M
----
----

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Can Fite Biopharma Ltd์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Can Fite Biopharma Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 405.00K์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 674.00K์ž…๋‹ˆ๋‹ค.

Can Fite Biopharma Ltd์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Can Fite Biopharma Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 9.44M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 5.10์ž…๋‹ˆ๋‹ค.

Can Fite Biopharma Ltd์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Can Fite Biopharma Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Can Fite Biopharma Ltd์˜ ์ด์ž์‚ฐ์€ 9.51M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 4.32์ž…๋‹ˆ๋‹ค.

Can Fite Biopharma Ltd์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Can Fite Biopharma Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Can Fite Biopharma Ltd์˜ ์ด๋ถ€์ฑ„๋Š” 3.92M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 6.46์ž…๋‹ˆ๋‹ค.

Can Fite Biopharma Ltd์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Can Fite Biopharma Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Can Fite Biopharma Ltd์˜ ์ด์ž๋ณธ์€ 5.59M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 2.87์ž…๋‹ˆ๋‹ค.

Can Fite Biopharma Ltd์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Can Fite Biopharma Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Can Fite Biopharma Ltd์˜ ์ˆœ์˜์—…์†Œ๋“์€ -9.95M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -22.39์ž…๋‹ˆ๋‹ค.

Can Fite Biopharma Ltd์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Can Fite Biopharma Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Can Fite Biopharma Ltd์˜ ์ˆœํˆฌ์ž๋Š” -2.00K์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -100.13์ž…๋‹ˆ๋‹ค.

Can Fite Biopharma Ltd์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Can Fite Biopharma Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Can Fite Biopharma Ltd์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 9.64M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 43.70์ž…๋‹ˆ๋‹ค.

Can Fite Biopharma Ltd์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Can Fite Biopharma Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -11.94์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 45.03์ž…๋‹ˆ๋‹ค.

Can Fite Biopharma Ltd์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Can Fite Biopharma Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -9.83M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -24.72์ž…๋‹ˆ๋‹ค.

Can Fite Biopharma Ltd์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Can Fite Biopharma Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -2426.67์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -107.56์ž…๋‹ˆ๋‹ค.

Can Fite Biopharma Ltd์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Can Fite Biopharma Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -178.24์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -32.08์ž…๋‹ˆ๋‹ค.

Can Fite Biopharma Ltd์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Can Fite Biopharma Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -105.48์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -27.90์ž…๋‹ˆ๋‹ค.

Can Fite Biopharma Ltd์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Can Fite Biopharma Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -9.95M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -22.39์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ